Strategies for Continued IRT Success During COVID-19 Date Published: Jun 24, 2020 Article Featured in Journal for Clinical Studies, this article discusses the challenges IRT customers face with the recent COVID-19 pandemic and how to mitigate these potential issues to avoid interrupting ongoing clinical trials. Discover best practices for: Distribution challengesScreening & enrollment challengesA properly configured and adaptive IRT system can enable organizations to remain flexible and agile enough to face any challenge. Signant Health’s team of IRT designers, developers, supply experts, and statisticians are available to consult on challenges and best practices. Download Now Share: LinkedIn0Tweet0 Recommended Resources Article A New Approach to Diagnosing and Treating Major Depressive Disorder Can a blood test predict treatment response to antidepressants? Recent research conducted by Signant’s scientific director, Steven Targum, M.D., along... Download Article Visual Analog Scale: Paper Versus Electronic Administration Comparison Increasing digitalization of clinical outcome assessments prompts questions about equivalence between data captured from paper and electronic instrument versions. Signant’s... Download Now Article How To Run a Successful, Decentralized Oncology Trial Oncology research continues to undergo rapid transformation, driven by a number of factors including: Increased interest in understanding the patient... Download Now